New Delhi: The first phase trial of the nasal decongestant covid vaccine is successful. Following this, the authorities approved the next trial of the vaccine in India. India’s first nasal vaccine is developed by Bharat Biotech. The experiment took place in people between the ages of 18 and 60 years old.
